Abstract
Build a world-class diabetes MSL program
Currently, about 246 million people worldwide have diabetes; this number is
expected to increase to 380 million by 2025, according to the International
Diabetes Foundation. Such staggering figures solidify diabetes' position as a
primary therapeutic area. They also indicate the value of medical science
liaisons who are building relationships within the diabetes medical community.
Today' s MSLs are key strategic drivers for product and overall company
success. Perhaps your company plans to enter the market or maybe your diabetes
MSL team needs an upgrade. In either case, The Toolkit for Diabetes MSL
Programs provides clear, easy-to-access guidance on all aspects of diabetes
MSL program management. The research focuses on these core areas:
- MSL structure and staffing
- MSL budgets
- MSL responsibilities and activities metrics
- KOL relationships and segmentation criteria
- MSL qualifications and experience levels
- KOL compensation
CEI has integrated its leading research in MSLs and thought leader management
with a growing expertise in therapeutic areas to create a highly customized,
data-driven report. You won' t find this information anywhere else! Use The
Toolkit or Diabetes MSL Programs to strengthen your diabetes MSL team and
improve the bottom line.
|